These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
835 related articles for article (PubMed ID: 22019659)
21. Sensory nerve conduction in demyelinating and axonal Guillain-Barré syndromes. Kuwabara S; Ogawara K; Misawa S; Mizobuchi K; Sung JY; Kitano Y; Mori M; Hattori T Eur Neurol; 2004; 51(4):196-8. PubMed ID: 15159599 [TBL] [Abstract][Full Text] [Related]
22. Campylobacter jejuni infection in Guillain-Barré syndrome: a prospective case control study in a tertiary care hospital. Sharma A; Lal V; Modi M; Vaishnavi C; Prabhakar S Neurol India; 2011; 59(5):717-21. PubMed ID: 22019657 [TBL] [Abstract][Full Text] [Related]
24. Childhood Guillain-Barré syndrome subtypes in northern India. Sankhyan N; Sharma S; Konanki R; Gulati S J Clin Neurosci; 2014 Mar; 21(3):427-30. PubMed ID: 24128771 [TBL] [Abstract][Full Text] [Related]
25. Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barre syndrome? Kuwabara S; Ogawara K; Misawa S; Koga M; Mori M; Hiraga A; Kanesaka T; Hattori T; Yuki N Neurology; 2004 Aug; 63(3):529-33. PubMed ID: 15304587 [TBL] [Abstract][Full Text] [Related]
26. Anti-ganglioside antibodies in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy in Chinese patients. Fan C; Jin H; Hao H; Gao F; Sun Y; Lu Y; Liu Y; Lv P; Cui W; Teng Y; Huang Y Muscle Nerve; 2017 Apr; 55(4):470-475. PubMed ID: 27464289 [TBL] [Abstract][Full Text] [Related]
27. Antiganglioside antibodies in Guillain-Barré syndrome and its related conditions. Shahrizaila N; Yuki N Expert Rev Neurother; 2011 Sep; 11(9):1305-13. PubMed ID: 21864076 [TBL] [Abstract][Full Text] [Related]
28. [Antiganglioside antibodies: when, which and for what]. Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721 [TBL] [Abstract][Full Text] [Related]
29. Serial electrophysiological findings in Guillain-Barré syndrome not fulfilling AIDP or AMAN criteria. Hosokawa T; Nakajima H; Unoda K; Yamane K; Doi Y; Ishida S; Kimura F; Hanafusa T J Neurol; 2016 Sep; 263(9):1709-18. PubMed ID: 27278064 [TBL] [Abstract][Full Text] [Related]
30. Axonal conduction block at intermediate nerve segments in pure motor Guillain-Barré syndrome. Hong YH; Sung JJ; Oh MY; Moon HJ; Park KS; Lee KW J Peripher Nerv Syst; 2011 Mar; 16(1):37-46. PubMed ID: 21504501 [TBL] [Abstract][Full Text] [Related]
31. [Follow-up study on the clinical characteristics and treatment effect of the different types of Guillain-Barré syndrome in children]. Wang XH; Zou LP; Wu HS; Fang F; Lü JL; Xiao J; Ding CH; Chen CH; Wang X; Jin H; Zhou WM; Cai FY Zhonghua Er Ke Za Zhi; 2011 Aug; 49(8):583-8. PubMed ID: 22093419 [TBL] [Abstract][Full Text] [Related]
32. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy. Créange A; Shahrizaila N; Salhi H; Lefaucheur JP; Yuki N J Peripher Nerv Syst; 2014 Jun; 19(2):115-20. PubMed ID: 24750296 [TBL] [Abstract][Full Text] [Related]
33. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Ho TW; Mishu B; Li CY; Gao CY; Cornblath DR; Griffin JW; Asbury AK; Blaser MJ; McKhann GM Brain; 1995 Jun; 118 ( Pt 3)():597-605. PubMed ID: 7600081 [TBL] [Abstract][Full Text] [Related]
34. Utility of neurophysiological criteria in Guillain Barre΄ syndrome: subtype spectrum from a tertiary referral hospital in India. Alexander M; Prabhakar AT; Aaron S; Thomas M; Mathew V; Patil AK Neurol India; 2011; 59(5):722-6. PubMed ID: 22019658 [TBL] [Abstract][Full Text] [Related]
35. Study on Electrophysiological Findings of Guillain Barre Syndrome Patients Attending the Department of Neurology in BSMMU. Das S; Khan RK; Alam SM; Chowdhury NH; Das P Mymensingh Med J; 2018 Jul; 27(3):631-640. PubMed ID: 30141456 [TBL] [Abstract][Full Text] [Related]
36. Electrodiagnostic and clinical aspects of Guillain-Barré syndrome: an analysis of 142 cases. Gupta D; Nair M; Baheti NN; Sarma PS; Kuruvilla A; J Clin Neuromuscul Dis; 2008 Dec; 10(2):42-51. PubMed ID: 19169089 [TBL] [Abstract][Full Text] [Related]
37. Sonographic evaluation of peripheral nerves in subtypes of Guillain-Barré syndrome. Mori A; Nodera H; Takamatsu N; Maruyama-Saladini K; Osaki Y; Shimatani Y; Kaji R J Neurol Sci; 2016 May; 364():154-9. PubMed ID: 27084237 [TBL] [Abstract][Full Text] [Related]
38. An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain-Barré syndrome with reversible conduction failure. Ogawa G; Kaida K; Kuwahara M; Kimura F; Kamakura K; Kusunoki S J Neuroimmunol; 2013 Jan; 254(1-2):141-5. PubMed ID: 23000056 [TBL] [Abstract][Full Text] [Related]
39. "Finger drop sign" in Guillain-Barré syndrome. George A; Abdurehiman P; James J Neurol India; 2009; 57(3):282-6. PubMed ID: 19587468 [TBL] [Abstract][Full Text] [Related]